New hematuria risk index IDs patients at low cancer risk

New hematuria risk index IDs patients at low cancer risk
A Hematuria Risk Index could identify cancer risk among patients with asymptomatic microscopic hematuria, according to a study published online Jan. 11 in the Mayo Clinic Proceedings.

(HealthDay)—A Hematuria Risk Index could identify cancer risk among patients with asymptomatic microscopic hematuria, according to a study published online Jan. 11 in the Mayo Clinic Proceedings.

Ronald K. Loo, M.D., from the Southern California Permanente Medical Group in Los Angeles, and colleagues conducted a of patients with asymptomatic hematuria who were referred to a urology consult and underwent full work-up. were used to passively follow patients for a diagnosis of urothelial or renal cancer.

The researchers found that, of 2,630 patients in the test cohort, 2.1 percent had a neoplasm and 1.9 percent had a pathologically-confirmed urinary tract cancer. The strongest predictors of cancer were being age 50 years or older and a recent history of gross hematuria. Male gender was also predictive of cancer. Smoking history and 25 or more per high powered field on a recent urinalysis were not significant predictors. These factors were used to develop a Hematuria with an area under the receiver operating characteristic curve (AUC) of 0.809. The risk index demonstrated similar performance in a validation cohort of 1,784 patients (AUC, 0.829). Of the validation cohort, 32 percent were identified as low risk and a cancer was detected in 0.2 percent. Cancer was detected in 11.1 percent of the 14 percent of the population identified as high risk.

"These data suggest that microscopic hematuria is an unreliable indicator of urinary tract malignancy," the authors write. "These findings may be used to simplify referral guidelines for evaluation in asymptomatic patients with microscopic hematuria and reduce the number of unnecessary work-ups."

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Gender, BMI impact bladder perforation during resection

Apr 17, 2012

(HealthDay) -- For patients with bladder tumors, female gender, low body mass index, and tumor characteristics correlate with the risk of bladder perforation during transurethral resection, according to research ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

8 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

9 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

15 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

16 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

17 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments